Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Non-canonical transferase and oxidase enzymes in the medicinal Kanna plant (Mesembryanthemum tortuosum) mediate a multistep cyclization cascade that forms the Kanna alkaloid scaffold, including the serotonin reuptake inhibitor mesembrine.
- Why it matters: Serotonergic natural products are typically built from tryptophan, but Kanna uses tyrosine and phenylalanine via unknown transformations, limiting understanding of how its serotonin-like molecules are made.
- What they did: The study elucidates Kanna alkaloid biosynthesis by identifying an unusual scaffold-forming strategy involving non-canonical transferase and oxidase enzymes, then providing mechanistic insight into how an activated intermediate undergoes cyclization.
- The result: By uncovering the pathway and mechanism, the work explains how plants repurpose unconventional metabolic building blocks and enzymes to produce serotonergic compounds with promise for therapeutics in neurological disorders.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.